Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Midgard

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Journal of Neurology|November 22, 2007
Opsoclonus myoclonus syndrome in two cases with neuroborreliosisG O Skeie, G Eldøen, B S Skeie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2001
Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pensionK M Myhr, T Riise, C Vedeler, et al.
Acta Neurologica Scandinavica|January 1, 1994
Absence of HTLV-1 related sequences in MS from high prevalence areas in western NorwayK M Myhr, P Frost, M Grønning, et al.
Journal of Neurology|December 14, 2023
Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based studyA Habbestad, J S Willumsen, J H Aarseth, et al.
European Journal of Neurology|December 6, 2005
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapsesF Sellebjerg, D Barnes, G Filippini, et al.
Neuroepidemiology|July 21, 2012
Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patientsJ Saltytė Benth, K-M Myhr, K I Løken-Amsrud, et al.
Acta Neurologica Scandinavica|March 1, 1992
Early prognostic factors for disability in multiple sclerosis, a European multicenter studyT Riise, M Grønning, O Fernández, et al.
Acta Neurologica Scandinavica|June 4, 2015
WT1 and interferon-β-vitamin D association in MS: a longitudinal studyT Holmøy, Q Y Esbensen, Ø Torkildsen, et al.
European Journal of Neurology|March 22, 2016
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patientsS Wergeland, K-M Myhr, K I Løken-Amsrud, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 5, 2019
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trialC Storm-Larsen, K-M Myhr, E Farbu, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Neurology|November 22, 2007
Opsoclonus myoclonus syndrome in two cases with neuroborreliosisG O Skeie, G Eldøen, B S Skeie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2001
Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pensionK M Myhr, T Riise, C Vedeler, et al.
Acta Neurologica Scandinavica|January 1, 1994
Absence of HTLV-1 related sequences in MS from high prevalence areas in western NorwayK M Myhr, P Frost, M Grønning, et al.
Journal of Neurology|December 14, 2023
Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based studyA Habbestad, J S Willumsen, J H Aarseth, et al.
European Journal of Neurology|December 6, 2005
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapsesF Sellebjerg, D Barnes, G Filippini, et al.
Neuroepidemiology|July 21, 2012
Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patientsJ Saltytė Benth, K-M Myhr, K I Løken-Amsrud, et al.
Acta Neurologica Scandinavica|March 1, 1992
Early prognostic factors for disability in multiple sclerosis, a European multicenter studyT Riise, M Grønning, O Fernández, et al.
Acta Neurologica Scandinavica|June 4, 2015
WT1 and interferon-β-vitamin D association in MS: a longitudinal studyT Holmøy, Q Y Esbensen, Ø Torkildsen, et al.
European Journal of Neurology|March 22, 2016
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patientsS Wergeland, K-M Myhr, K I Løken-Amsrud, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 5, 2019
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trialC Storm-Larsen, K-M Myhr, E Farbu, et al.
Pageof 3